Skip to main content

Home/ Cerebral Palsy/ Group items tagged PPI

Rss Feed Group items tagged

Lee Vander Loop

Non-interventional Study to Evaluate the Change in Symptoms Scores and Treatment Respon... - 0 views

  •  
    Objective of the study is to describe the change in GerdQ sum scores, after a 4-week period of systematic treatment with PPIs(using GerdQ questionnaire). The secondary objectives are: to measure the response at the current treatment after a 4-week period of systematic treatment and to identify the percentage of patients which require alterations of their treatment (GerdQ questionnaire)"
Lee Vander Loop

To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Ero... - 0 views

  •  
    Purpose of this study is to assess the effectiveness and safety of rabeprazole sodium, an inhibitor of gastric acid secretion of the protein pump inhibitor (PPI) class, compared with placebo in the treatment of gastrointestinal esophageal reflux disease (GERD) in infants 1 to 11 months of age.
Lee Vander Loop

Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplic... - 0 views

  •  
    Future planned study with the objective of evaluating the relative merits, safety and effectiveness of the tailored TIF2 procedure in treating GERD patients who have persistent GERD symptoms despite PPI therapy.The secondary objective of the study is to evaluate the effectiveness of the tailored TIF procedure in restoring the antireflux barrier and eliminating gastroesophageal reflux.
Lee Vander Loop

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Ga... - 0 views

  •  
    Study to assess the efficacy of pantoprazole for the treatment of infants with symptomatic Gastroesophageal Reflux Disease (GERD)
Lee Vander Loop

A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and... - 0 views

  •  
    Study is to evaluate the pharmacokinetics (blood levels), pharmacodynamics (how the drug acts on the body), and the safety of rabeprazole sodium for the treatment of gastroesophageal reflux disease (GERD) in new borns and pre-term infants (less than 44 weeks of age).
Lee Vander Loop

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than... - 0 views

  •  
    Purpose of this completed study is to provide additional information on safety and tolerability after multiple doses of pantoprazole in infants
Lee Vander Loop

Proton Pump Inhibitor Therapy and Bone Density in Premature Infants - 0 views

  •  
    Objective is to determine if a connection exists between proton pump inhibitor antacids and decreased rate of bone mineralization in neonates
1 - 7 of 7
Showing 20 items per page